Public Citizen Calls on Presidential Candidates, Parties to Pledge Not to Use Dangerous, Manipulative Deepfakes
Statement: FDA Must Reject Tanezumab as a Treatment for Osteoarthritis Due to Unacceptable Dangers, Little to No Benefit
Testimony before the FDA’s Cellular, Tissue and Gene Therapies Advisory Committee Regarding SRP-9001 (delandistrogene moxeparvovec) for the Treatment of Duchenne Muscular Dystrophy May 12, 2023
Health Research Group Study Examines Use of Placebos in Clinical Trials Testing New Drugs for Life-Threatening Diseases April 24, 2018